P&G Plans Health Care Expansion As Prilosec OTC Sales Continue Falling

Double-digit percent volume growth in developing markets helped drive Procter & Gamble's health care sales up 5 percent, but the firm says competition for Prilosec OTC continues to cut into its revenues